WASHINGTON — Amazon.com Inc. AMZN, -2.70% will be able to close its purchase of 1Life Healthcare Inc. ONEM, +2.87%, the operator of the One Medical line of primary-care clinics, without a legal challenge by antitrust enforcers.
The Federal Trade Commission won’t sue in time to block the $3.9 billion deal, including debt, but will continue its investigation of the merger, an agency spokesman said. The decision clears a path for Amazon to substantially expand its healthcare offerings and operate physical medical clinics. Amazon has invested in the healthcare space for years, including with an online pharmacy and other health ventures.
This article was originally published by Marketwatch.com. Read the original article here.
